| Application no. and date | 15202042.6 (espacenet) (Federated) (European Patent Register), 20091013 | | Patent/reg. no. and date | DK/EP 3029154, 20171004 | | Publication date | 20160608 | | Priority no. and date | US 106491 P, 20081017 | | EP pub. no. and date |
EP 3029154 20160608 | | Effective date | | | Applicant/owner | Geron Corporation, 149 Commonwealth Drive
Menlo Park, CA 94025, US | | Applicant ref. no. | P23065DKEP | | Inventor | RATAIN, Mark, J., 1040 West Oakdale Avenue
Chicago, IL 60657, US,
HARLEY, Calvin, B., 1177 Sandalwood Drive
Murphys, CA 95247, US,
ELIAS, Laurence, 41 Alvarado Road
Berkeley, CA 94705, US,
BENEDETTI, Fabio, 301 Main Street, Apt. 26h
San Francisco, CA 94105, US,
SMITH, Jennifer, 2052 Menalto Ave
Menlo Park, CA 94025, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | C12Q 1/68 (2006.01) | | Title | Fremgangsmåde til identificering af en patients følsomhed over for en telomerase-inhiberende terapi | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
